Pcn372 - Evidence Map of Patient Reported Outcome Studies in Non-Hodgkin Lymphoma Since 1960

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.454
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Upfront Ahsct in Non Hodgkin Lymphoma-Better Outcome?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Studies Identify Non-Hodgkin Lymphoma Suppressor

Cancer Discovery
Oncology
2015English

Patient-Reported Outcomes of Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large-Cell Lymphoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Evidence Map of Costs Studies in Cystic Fibrosis Since 2000

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Non-Hodgkin Lymphoma

2020English

Non-Hodgkin Lymphoma of the Stomach in a Patient Treated With Natalizumab

Clinical Medicine Insights: Oncology
Oncology
2015English

Patient-Reported Outcome Measurement

Journal of the Royal Society of Medicine
Medicine
2010English

Differences in Outcome of Patients With Syncytial Variant Hodgkin Lymphoma Compared With Typical Nodular Sclerosis Hodgkin Lymphoma

Therapeutic Advances in Hematology
Hematology
2016English

Stage I Non-Hodgkin Lymphoma: Difference in Survival Outcome by Primary Extranodal Site of Involvement

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy